Omic Biosystems is to create and provide state-of-the-art technological solutions
for the studies of omics biosciences. Its discoveries, reagents, systems, and services will enable acceleration in scientific exploration and discoveries that make human life better

Quick Launch

Dr. Feng Tao made an introduction of Omic Biosystems and DiART at the Columbia TechBreakfast. [see video]

Omic Biosystems offers New DiART Products and Omics Services

DiART is a new generation Isobaric Products for Large Scale Quantitative Omics Studies. Applications include proteomics, phosphoproteomics, protein post-translational modifications, metabolomics and more systems biology areas
Isobaric method is one of most commonly used proteomic methods, #1 in published LC-MS/MS based proteomic studies
DiART method allows omics quantification at a brand-new level through "large-scale labeling" (illustrated below). Sensitivity, precision and reproducibility of the isobaric method are significantly improved.

News about Omic Biosystems

In April 2013, UMUC completed two Omic Biosystems Capstone projects which investigated DiART enabled omics services and integrated multi-omics applications for life science and biotechnology
Omic Biosystems attended the 2013 US HUPO conference in Baltimore, MD on March 10-13, 2013. DiART products and large scale DiART labeling method were introduced.
Two new DiART application studies in proteomics and metabolomics published by scientists from the University of Maryland and Beijing Institute of Genomics in March, 2012
More news about Omic Biosystems

Omics BioScience and Biotechnology News

National Cancer Institute of the National Institutes of Health is to provide $10 million SBIR contracts including projects that relate to 'Omics bioscience based diagnostics, therapeutics, and technologies for advancing proteomics, metabolomics, and glycomics
NHLBI to Fund Lung Disease 'Omics Scholars Program
The National Institutes of Health issued a RFA-AI-12-027 and calls for studies of “OMICS” Technologies for Predictive Modeling of Infectious Diseases
In the National Bioeconomy Blueprint on April 26, 2012, it suggests that development of Omics Technologies is essential to today and tomorrow's National Bioeconomy

Upcoming Events